A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma

被引:59
作者
Kao, Steven C. [1 ,2 ,3 ]
Fulham, Michael [3 ,4 ]
Wong, Kirby [4 ]
Cooper, Wendy [3 ,4 ,5 ]
Brahmbhatt, Himanshu [6 ]
MacDiarmid, Jennifer [6 ]
Pattison, Scott [6 ]
Sagong, Jin Og [1 ]
Huynh, Yennie [2 ]
Leslie, Felicity [2 ]
Pavlakis, Nick [3 ,7 ]
Clarke, Stephen [3 ,7 ]
Boyer, Michael [1 ,3 ]
Reid, Glen [2 ,3 ]
van Zandwijk, Nico [2 ,3 ]
机构
[1] Chris OBrien Lifehouse, Sydney, NSW, Australia
[2] Asbestos Dis Res Inst, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW 2006, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Univ Western Sydney, Sydney, NSW, Australia
[6] EnGenelC Ltd, Sydney, NSW, Australia
[7] Royal N Shore Hosp, Sydney, NSW, Australia
关键词
PHASE-III; THERAPY; CISPLATIN;
D O I
10.1164/rccm.201503-0461LE
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1467 / 1469
页数:3
相关论文
共 8 条
[1]  
Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
[2]   Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics [J].
MacDiarmid, Jennifer A. ;
Mugridge, Nancy B. ;
Weiss, Jocelyn C. ;
Phillips, Leo ;
Burn, Adam L. ;
Paulin, Richard P. ;
Haasdyk, Joel E. ;
Dickson, Kristie-Ann ;
Brahmbhatt, Vatsala N. ;
Pattison, Scott T. ;
James, Alexander C. ;
Al Bakri, Ghalib ;
Straw, Rodney C. ;
Stillman, Bruce ;
Graham, Robert M. ;
Brahmbhatt, Himanshu .
CANCER CELL, 2007, 11 (05) :431-445
[3]   Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma [J].
Reid, G. ;
Pel, M. E. ;
Kirschner, M. B. ;
Cheng, Y. Y. ;
Mugridge, N. ;
Weiss, J. ;
Williams, M. ;
Wright, C. ;
Edelman, J. J. B. ;
Vallely, M. P. ;
McCaughan, B. C. ;
Klebe, S. ;
Brahmbhatt, H. ;
MacDiarmid, J. A. ;
van Zandwijk, N. .
ANNALS OF ONCOLOGY, 2013, 24 (12) :3128-3135
[4]   Circulating microRNAs: Association with disease and potential use as biomarkers [J].
Reid, Glen ;
Kirschner, Michaela B. ;
van Zandwijk, Nico .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (02) :193-208
[5]   A Practical Guide of the Southwest Oncology Group to Measure Malignant Pleural Mesothelioma Tumors by RECIST and Modified RECIST Criteria [J].
Tsao, Anne S. ;
Garland, Linda ;
Redman, Mary ;
Kernstine, Kemp ;
Gandara, David ;
Marom, Edith M. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) :598-601
[6]   Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada [J].
van Meerbeeck, JP ;
Gaafar, R ;
Manegold, C ;
Van Klaveren, RJ ;
Van Marck, EA ;
Vincent, M ;
Legrand, C ;
Bottomley, A ;
Debruyne, C ;
Giaccone, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6881-6889
[7]   Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma [J].
Vogelzang, NJ ;
Rusthoven, JJ ;
Symanowski, J ;
Denham, C ;
Kaukel, E ;
Ruffie, P ;
Gatzemeier, U ;
Boyer, M ;
Emri, S ;
Manegold, C ;
Niyikiza, C ;
Paoletti, P .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2636-2644
[8]   Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma [J].
Zauderer, Marjorie G. ;
Kass, Samantha L. ;
Woo, Kaitlin ;
Sima, Camelia S. ;
Ginsberg, Michelle S. ;
Krug, Lee M. .
LUNG CANCER, 2014, 84 (03) :271-274